As described in the resisting cell death section above, SNHG17 reduces mitochondrial autophagy by downregulating Parkin in non-tumor diseases (27), and Parkin plays a role in glucose metabolism and the Warburg effect as a p53 target gene (74). The gene discussed is TP53; the disease is neoplasm.